|
USP15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.07040000038883E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05289999996483E-06 |
| Normal-vs-Stage2 |
7.915500E-03 |
| Normal-vs-Stage3 |
1.358850E-03 |
| Normal-vs-Stage4 |
1.556360E-03 |
| Stage1-vs-Stage2 |
7.652800E-01 |
| Stage1-vs-Stage3 |
3.760800E-01 |
| Stage1-vs-Stage4 |
7.851600E-01 |
| Stage2-vs-Stage3 |
4.490600E-01 |
| Stage2-vs-Stage4 |
6.692600E-01 |
| Stage3-vs-Stage4 |
6.682200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.71460000034196E-07 |
| Normal-vs-AfricanAmerican |
7.583800E-02 |
| Normal-vs-Asian |
6.397300E-03 |
| Caucasian-vs-AfricanAmerican |
1.456160E-01 |
| Caucasian-vs-Asian |
6.001400E-01 |
| AfricanAmerican-vs-Asian |
2.241800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.85280000003707E-06 |
| Normal-vs-Female |
2.96970000002172E-06 |
| Male-vs-Female |
5.750600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.133200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.36419999996473E-06 |
| Normal-vs-Age(61-80Yrs) |
1.78878999999021E-05 |
| Normal-vs-Age(81-100Yrs) |
2.991700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.592000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.023800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.027000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.529000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.763400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.372000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.57829999999959E-05 |
| Normal-vs-Grade 2 |
1.1051000003981E-07 |
| Normal-vs-Grade 3 |
1.964010E-04 |
| Normal-vs-Grade 4 |
3.361500E-02 |
| Grade 1-vs-Grade 2 |
3.169600E-01 |
| Grade 1-vs-Grade 3 |
5.803600E-02 |
| Grade 1-vs-Grade 4 |
3.891700E-02 |
| Grade 2-vs-Grade 3 |
1.999810E-02 |
| Grade 2-vs-Grade 4 |
9.174100E-02 |
| Grade 3-vs-Grade 4 |
7.867000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.87990003961158E-09 |
| Normal-vs-ccB subtype |
2.659600E-03 |
| ccA subtype-vs-ccB subtype |
4.202500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01230000004726E-06 |
| Normal-vs-N1 |
2.263600E-01 |
| N0-vs-N1 |
9.328800E-01 |
|
|
